Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Authors: John H Beigel, Yajing Bao, Joy Beeler, Weerawat Manosuthi, Alex Slandzicki, Sadia Dar, John Panuto, Richard L Beasley, Santiago Pérez-Patrigeón, Gompol Suwanpimolkul, Marcelo Losso, Natalie McClure, Dawn R. Bozzolo, Christopher A. Myers, H. Preston Holley, Justin D. Hoopes, H. Clifford Lane, Michael D. Hughes, Richard T. Davey, Michael Winnie, Dinh V Dinh, Raghu R. Seethala, Hiram Garcia, Joe Pouzar, Michael Seep, Ernie Riffer, Belinda Bart, Sadia Dar, Melanie Hoppers, John Panuto, Heather Rowe, Alex Slandzicki, Cameron R. Wolfe, Donna DeSantis, Barr Baynton, Richard L Beasley, Norman Markowitz, Zebediah A Stearns, Josalyn Cho, Marcy Goisse, Thomas Wolf, Jennifer Kay, Nila J. Dharan, William Fitzgibbons, Mark Woodruff, Todd Bell, Thomas Lenzmeier, Robert T. Schooley, Marie‐Carmelle Elie, Patricia Winokur, Robert W. Finberg, Chris Hurt, Pablo Tebas, Fred R. Sattler, Madhavi Ampajwala, Donald H. Batts, Mark Bloch, Richard D. Moore, Dominic E. Dwyer, Javier Romo-Garcia, Santiago Perez Patrigeon, Ana Patricia Rodríguez Zulueta, Weerawat Manosuthi, Ploenchan Chetchotisakd, Kiat Ruxrungtham, Anchalee Avihingsanon, Gompol Suwanpimolkul, Winai Ratanasuwan, Sergio Lupo, Liliana Trape, Marcelo Losso, Laura Moreno Macias, Gustavo Lopardo, Laura Barcelona, Analía Mykietuk, María Fernanda Alzogaray - The Lancet 2017 cited by 99